Parker Institute for Cancer Immunotherapy

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

Parker Institute for Cancer Immunotherapy
May 12, 2025, 06:09 | Career
Karen Knudsen: Grateful to have been recognized as one of the Most Influential Women in the Bay Area
Karen Knudsen, CEO of Parker Institute for Cancer Immunotherapy, shared a post on LinkedIn: "Grateful…
May 7, 2025, 01:43 | Blog
Karen Knudsen: Discussing the PICI Model at the Milken Institute Global Conference
Karen Knudsen, Executive Strategic Advisor and Immediate Past CEO of the American Cancer Society (ACS), shared…
May 4, 2025, 08:54 | Blog
Ana Kreacic: Heading back to Milken Institute's Global Conference next week
Ana Kreacic, Chief Operating Officer of Oliver Wyman Forum, posted on LinkedIn: "I'm heading back…
May 2, 2025, 18:25 | Science
LOXHD1 Identified as Immunotherapy Target in Ewing Sarcoma - Parker Institute for Cancer Immunotherapy
Parker Institute for Cancer Immunotherapy shared a post on X: "Few cancers rob young lives…
May 1, 2025, 11:47 | Blog
Karen Knudsen: Redefining How Parker Institute Accelerates Science to Improve Lives
Karen Knudsen, CEO of Parker Institute for Cancer Immunotherapy, shared a post on LinkedIn: "The…
Apr 23, 2025, 11:43 | Blog
Critical challenges in cell therapy development - Friends of Cancer Research
Friends of Cancer Research shared a post on LinkedIn: "Speakers Announced! Friends of Cancer Research and…
Apr 13, 2025, 16:12 | Blog
Dr. Ira Mellman Joins the Parker Institute as President of Research
Life’s biggest breakthroughs often come at the crossroads of experience and bold ambition. For Dr.…
Apr 13, 2025, 04:56 | Blog
Karen Knudsen: Parker Institute for Cancer Immunotherapy is an organization built to make bold moves in science
Karen Knudsen, CEO of Parker Institute for Cancer Immunotherapy, posted on LinkedIn: "As I wrap up…
Apr 11, 2025, 09:33 | Blog
Ira Mellman has joined PICI as President of Research
Parker Institute for Cancer Immunotherapy posted on X: "Turning all cancers into curable diseases takes…
Apr 5, 2025, 06:19 | Blog
Karen Knudsen: Wrapping up my first days as CEO of the Parker Institute for Cancer Immunotherapy
Karen Knudsen, Executive Strategic Advisor and Immediate Past CEO of the American Cancer Society (ACS),…
Apr 2, 2025, 10:01 | Career
Karen Knudsen: I’ve taken the helm of Parker Institute for Cancer Immunotherapy (PICI) as CEO
Karen Knudsen, Executive Strategic Advisor and Immediate Past CEO of the American Cancer Society (ACS),…
Apr 1, 2025, 09:13 | Blog
Parker Institute for Cancer Immunotherapy Welcomes Karen Knudsen as Chief Executive Officer
Parker Institute for Cancer Immunotherapy posted on X: "Join us in welcoming Karen Knudsen as…
Mar 31, 2025, 16:23 | Career
Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy
Parker Institute for Cancer Immunotherapy shared a post on LinkedIn: "Please join us in welcoming…
Feb 8, 2025, 13:24 | Blog
Cancer immunotherapy isn’t just treatment - it’s a breakthrough
Parker Institute for Cancer Immunotherapy shared a post on LinkedIn by The Nobel Prize adding:…
Jan 25, 2025, 04:17 | Insight
Crystal L. Mackall - Candidate for Board of Directors of AACR
The voting for the 2025 AACR Annual Election is now open, where members will vote…
Nov 24, 2024, 10:30 | Blog
Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research
Donor-powered initiative fuels next generation of scientific innovators, expands equity in cancer research The Parker…
Nov 16, 2024, 15:56 | Insight
Michelle Monje: GD2-CAR T Cell Therapy for H3K27M+Diffuse Midline Gliomas
Michelle Monje, Professor of Pediatric Neuro-Oncology in the Department of Neurology and Neurological Sciences at…
Oct 29, 2024, 12:27 | Blog
Bernard A. Fox: THINK TANK VIII - A vision of what Immuno-oncology is and challenges us to consider what it can be
Bernard A. Fox, Co-Founder, President, and CEO of UbiVac, shared a post on LinkedIn: "THINK…
Oct 11, 2024, 18:22 | Blog
Imagine giving your immune system’s cancer-fighting cells a powerful energy boost to take on tumors - Parker Institute for Cancer Immunotherapy
Yan Leyfman shared a post by Parker Institute for Cancer Immunotherapy on LinkedIn, adding: "Pioneering work…
Aug 20, 2024, 12:37 | Career
Lawrence Fong takes role as Scientific Director of Fred Hutch Integrated Research Centers
Lawrence Fong was recently appointed as the Scientific Director of the Integrated Research Centers at…
Aug 7, 2024, 17:21 | Career
Antoni Ribas and Jedd Wolchok selected as 2024 Fellows of the Academy of Immuno-Oncology
Parker Institute for Cancer Immunotherapy shared on X: “Congrats to PICI Center Directors Antoni Ribas…
Jul 18, 2024, 09:35 | Insight
ctDNA variant-specific differences as potential mPDAC prognostic biomarker - PICI
Parker Institute for Cancer Immunotherapy (PICI) shared a post on X about a recent paper titled…
Jul 12, 2024, 07:47 | Blog
Potential breakthrough for patients with relapsed or refractory large B-cell lymphoma - Parker Institute for Cancer Immunotherapy
Yan Leyfman, Co-Founder and Executive Director at MedNews Week,  shared a posted by Parker Institute…
Jul 1, 2024, 15:04 | Blog
2024 class of Early Career Researcher recipients - Parker Institute for Cancer Immunotherapy
Parker Institute for Cancer Immunotherapy made the following post on X: "PICI is thrilled to award…
May 1, 2024, 19:24 | Blog
SIOP Women Leaders in Paediatric Oncology Network celebrates Dr. Crystal Mackall
SIOP Women Leaders in Paediatric Oncology Network shared on X/Twitter: “We celebrate women leaders in…
Apr 15, 2024, 02:29 | Insight
Evan Weber: Transcription factors that drive beneficial memory programs in CAR T cells
Evan Weber, Assistant Professor of Pediatrics at the University of Pennsylvania Perelman School of Medicine,…
All: 26 Posts: 1 - 100
Special Coverage